CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

CeriBell, Inc.NASDAQ: CBLL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 37.66M shares rose 5.0% year over year, behind the +38.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 1.2% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +5.0% toward the trailing-twelve-month pace of +38.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
37.66M+1.2% QoQ
Last fiscal yearDec 2025
36.54M+205.8% YoY
LTMMar 2026
37M+38.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.0%——
1 year+205.8%——
3-year CAGR+16.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
36.54M USD
Year-over-year change
+205.8%
3-year CAGR
+16.1%

Weighted Avg Shares (Diluted) vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 weighted avg shares (diluted) of 37M shares is the 3rd highest of the 7 companies compared; the peer median is 31.03M shares.
  • Its year-over-year change of +38.8% is the 2nd highest of 7, against a peer median of +9.9%.
  • Over three fiscal years its annual growth of +16.1% compares with a peer median of +9.1%.
CBLL Competitors Peer median
Weighted Avg Shares (Diluted) for CBLL and competitors
Company Period LTM YoY 3-year CAGR
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
LIVNLivaNova PLCLTM Sep 202656.03M +2.3%+0.6%
CBLLCeriBell, Inc.LTM Mar 202637M +38.8%+16.1%
NPCENeuroPace, Inc.LTM Mar 202633.11M +10.6%+10.0%
BWAYBrainsWay Ltd.LTM Mar 202628.96M -18.0%-13.7%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
ECORelectroCore, Inc.LTM Mar 20268.43M +9.1%+21.5%
Peer median (excluding CBLL) 31.03M+9.9%+9.1%

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.92M45.23M65.44M89.06M
Cost of Revenue4.43M7.06M8.69M10.79M
Gross Profit21.49M38.16M56.75M78.27M
Gross Margin82.9%84.4%86.7%87.9%
Research & Development7.24M9M13.56M19.14M
Selling, General & Admin50.27M59.21M82.9M117.53M
Operating Expenses57.51M68.2M96.46M136.68M
Depreciation & Amortization497K847K1.14M1.34M
EBITDA(35.06M)(26.51M)(37.32M)(50.18M)
EBITDA Margin-135.3%-58.6%-57.0%-56.3%
Operating Income(36.02M)(30.04M)(39.71M)(58.4M)
Operating Margin-139.0%-66.4%-60.7%-65.6%
Interest Income0000
Interest Expense1.6M2.1M1.99M1.89M
Other Income / Expenses(1.14M)588K(746K)4.99M
Income Before Tax(37.16M)(29.45M)(40.46M)(53.41M)
Pre-Tax Margin-143.4%-65.1%-61.8%-60.0%
Income Tax Expense2K11K00
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Net Margin-143.4%-65.1%-61.8%-60.0%
EPS (Basic)(1.59)(1.26)(3.39)(1.46)
EPS (Diluted)(1.59)(1.26)(3.39)(1.46)
Weighted Avg Shares23.32M23.32M11.95M36.54M
Weighted Avg Shares (Diluted)23.32M23.32M11.95M36.54M

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.